Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Julie Guglielmo, PharmD, BCOP

Articles by Julie Guglielmo, PharmD, BCOP

a vibrant microscopic view of malignant hematologic cells, their structure distorted and disorganized, while GFH009, represented by a glowing pathway | Image Caption: catalin | stock.adobe.com

Efficacy and Safety in CPX-351 vs 7+3 in Adults Younger Than 60 Years With AML-MRC or t-AML

ByVera Pervitsky, PharmD, BCOP, BCPS,Ila M. Saunders, PharmD, BCOP, DipACLM, FHOPA,Mimi Lo, PharmD, BCOP, BCPS,Rebecca Young, PharmD, BCOP,Benjamin Moskoff, PharmD, BCOP,Yunyi Ren, MS,Machelle Wilson, PhD,Brian A. Jonas, MD, PhD, FACP,Marisela Banez, PharmD, BCOP, BCPS,Julie Guglielmo, PharmD, BCOP

August 7th 2025

CPX-351 shows promise for younger adults with therapy-related AML, offering improved survival post-transplant despite lower initial remission rates.

Latest Updated Articles

Trending on Pharmacy Times

FDA Approves Reformulated Ranitidine After 5-Year Absence

Gluteus Maximus Muscle Shape Changes Tied to Aging, Frailty, and Type 2 Diabetes

Durvalumab Receives FDA Approval for Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

FDA Approves Gene Replacement Therapy Itvisma for Patients With Spinal Muscular Atrophy

Incidence of Invasive Pneumococcal Disease in Children Has Significantly Increased Postpandemic

© 2025 MJH Life Sciences^®

All rights reserved.